Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147–2160. doi:10.1007/s12325-019-00991-w

Object Details

• Location: Deutsche Nationalbibliothek Frankfurt am Main
• ISSN: 1865-8652
• Extent: Online-Ressource
• Language: Englisch
• Notes: online resource.

References and Relationships

• Bibliographic citation: Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147–2160. doi:10.1007/s12325-019-00991-w ; volume:37 ; number:2 ; day:14 ; month:12 ; year:2019 ; pages:955-957 ; date:2.2020 ; Advances in therapy ; 37, Heft 2 (14.12.2019), 955-957, 2.2020

Contributors, Places and Time

• Creator: Song, Jinlin ; Gao, Wei ; Xie, Jipan ; Tiwana, Simran
• Contributor: SpringerLink (Online service)

Further information

• DOI: 10.1007/s12325-019-01168-1
• URN: urn:nbn:de:101:1-2020050321573651552962
• Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
• Last update: 14.08.2025, 11:02 AM CEST